Barr, FDA Will Meet On Plan B Switch; Agency Says Rulemaking Not Needed
This article was originally published in The Tan Sheet
Executive Summary
The approval process for the over-the-counter sale of Barr's emergency contraceptive Plan B could be "wrapped up in a matter of weeks if [Barr and FDA] work diligently" together, according to an FDA spokesperson